Endotronics Inc said it is
restructuring its workforce to reduce payroll costs by
terminating 75 full-time and four part-time employees, or 33
pct of its total ranks.
    The company said despite the cutbacks it remains commited
to development of promising new areas and it intends "to
maintain our research commitment to our programs in cancer
immunotherapy and a new Hepatitis-B vaccine."
 Reuter
&#3;